Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study
Authors:
- 14 April 2008
- journal article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 62 (9) , 1373-1378
Abstract
Introduction: Statins have diverse anti-inflammatory effects in addition to their lipid-lowering ability. This study assesses the rate of chronic obstructive pulmonary disease (COPD) exacerbation and intubations in patients taking statins. Methods: This is a retrospective cohort study of 185 patients with COPD exacerbation, with a 1-year follow-up. Outcomes examined were repeat hospitalisation and intubations for COPD exacerbation. Baseline characteristics for which the p-value was ≤ 0.10 were considered as covariates for inclusion in a multivariate model. Results: The statin group had fewer episodes of exacerbation and required intubation fewer times than the subjects not receiving statins (p < 0.0001 for both outcomes). Unadjusted odds ratios (OR) for no statin use vs. statin use were 9.54 (95% CI: 4.54–20.02) for exacerbation and 10.47 (CI: 4.56–24.01) for intubation. The OR, adjusted for the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ORa), were 2.35 (CI: 1.01–5.50) for non-statin users exhibiting an exacerbation and 10.36 (CI: 2.77–38.76) for this group requiring intubation, compared with statin users. Similarly, ORa for long-acting β2 agonists as a covariate were 3.01 (CI: 1.46–6.10) for exacerbation and 8.89 (CI: 3.67–21.32) for intubation. Time to outcome during the observation period was reduced by statins with the hazard ratio (HR) for exacerbation of 0.19 (CI: 0.06–0.14); HR for statins reducing intubation was 0.14 (95% CI: 0.10–0.30). Conclusions: These data suggest that the use of statins may be associated with lower incidence of both exacerbations and intubations in patients with COPD.Keywords
This publication has 23 references indexed in Scilit:
- Inflammation in chronic obstructive pulmonary disease: implications for new treatment strategies.Current Medicinal Chemistry, 2007
- Statin use is associated with reduced mortality in COPDEuropean Respiratory Journal, 2006
- Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary DiseaseThe Journal of Immunology, 2006
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJACC, 2006
- COPD—pharmakologische Basisbehandlung und Zukunft der antiinflammatorischen TherapieMedizinische Klinik, 2006
- Is Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) a Risk Factor for Cardiovascular Events?COPD: Journal of Chronic Obstructive Pulmonary Disease, 2006
- Simvastatin Inhibits Cigarette Smoking–induced Emphysema and Pulmonary Hypertension in Rat LungsAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Cardiovascular Disease in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Chronic obstructive pulmonary disease: molecular and cellularmechanismsEuropean Respiratory Journal, 2003
- Tests for departure from normality: Comparison of powersBiometrika, 1977